| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/03/1999 | EP0899337A2 FtsY polynucleotides and polypeptides of Stapyloccoccus aureus belonging to the signal recognition protein family |
| 03/03/1999 | EP0899336A2 Streptococcus pneumoniae spoIIIE protein |
| 03/03/1999 | EP0899335A2 MurB gene from Staphylococcus aureus |
| 03/03/1999 | EP0899334A2 FtsZ polypeptides from Streptococcus pneumoniae |
| 03/03/1999 | EP0899333A2 Ribonucleotide reductase gene nrdD from Staphylococcus aureus |
| 03/03/1999 | EP0899332A2 The G-protein coupled receptor HFIAO41 |
| 03/03/1999 | EP0899329A2 DextranaseB gene from Streptococcus pneumoniae |
| 03/03/1999 | EP0899261A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists |
| 03/03/1999 | EP0898969A2 Neospora vaccine |
| 03/03/1999 | EP0898578A1 STREPTOCOCCUS PNEUMONIAE TYROSYL-tRNA SYNTHETASE |
| 03/03/1999 | EP0898577A1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE |
| 03/03/1999 | EP0898478A1 Stimulation of host defence mechanisms against tumors |
| 03/03/1999 | EP0898477A1 Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
| 03/03/1999 | EP0820462B1 Hydrolysis and photocleavage of nucleic acid using a metal complex |
| 03/03/1999 | EP0724570B1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 03/03/1999 | EP0677061B1 Polypeptides and anti-hiv agents prepared therefrom |
| 03/03/1999 | EP0673420B1 Mammalian receptors for interleukin-10 (il-10) |
| 03/03/1999 | EP0620850B1 Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines |
| 03/03/1999 | EP0565590B1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
| 03/03/1999 | EP0563288B1 Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines |
| 03/03/1999 | CN1209810A Carbapenem derivatives and antimicrobials |
| 03/03/1999 | CN1209748A Nucleoside analogs in combination therapy of herpes simplex infections |
| 03/03/1999 | CN1209455A DNA of encoding plasminogen excited protein |
| 03/03/1999 | CN1209435A Chinese trichosanthes protein, preparation method and use in pharmacy |
| 03/03/1999 | CN1209315A Improvement of auxiliary material containing chlorohaxanpyridine acetate |
| 03/03/1999 | CN1042299C Preparation method for improved oral preparation of dideoxy purine nucleosides |
| 03/03/1999 | CN1042297C Method for preparing medicinal food |
| 03/03/1999 | CA2242313A1 Signal recognition particle polypeptides and polynucleotides |
| 03/03/1999 | CA2218672A1 Antimicrobial agents for eucaryotic microorganisms and methods of growth suppression of eucaryotic microorganisms using these agents |
| 03/02/1999 | US5877342 Skin disorders; respiratory system disorders; cardiovascular disorders |
| 03/02/1999 | US5877321 Neurokinin receptor |
| 03/02/1999 | US5877298 Acellular pertussis vaccines and methods of preparing thereof |
| 03/02/1999 | US5877282 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 03/02/1999 | US5877274 Antimicrobial cationic peptides |
| 03/02/1999 | US5877213 Compositions and methods for therapy and prevention of cancer, AIDS, and anemia |
| 03/02/1999 | US5877193 Use of N-(4-aryl-thiazol-2-yl)-sulfonamides |
| 03/02/1999 | US5877178 Aids therapy |
| 03/02/1999 | US5877162 Short external guide sequences |
| 03/02/1999 | US5877159 The gene may encode, e.g., a vaccine antigen, an therapeutic agent, an immunoregulatory agent or a anti-sense rna or a catalytic rna. |
| 03/02/1999 | US5876979 RNA component of mouse, rat, Chinese hamster and bovine telomerase |
| 03/02/1999 | US5876966 Compounds and methods for the stimulation and enhancement of protective immune responses and IL-12 production |
| 03/02/1999 | US5876931 Identification of genes |
| 03/02/1999 | US5876920 Screening for vircides and viral suppressors by contacting infected cell with agent, determining if suppression of prenylation of proteins; against hepatitis virus |
| 03/02/1999 | US5876749 Pharmaceutical composition |
| 03/02/1999 | US5876737 Use of salicin as an anti-irritative active compound in cosmetic and topical dermatological preparations |
| 03/02/1999 | US5876733 Complexing |
| 03/02/1999 | US5876732 Envelope protein |
| 03/02/1999 | US5876731 Candidate vaccines against hiv-1 and which are useful in diagnostic application. |
| 03/02/1999 | US5876726 Vaccines and methods for preventing and treating fescue toxicosis in herbivores |
| 03/02/1999 | US5876725 Actinobacillus pleuropneumoniae transferrin binding protein vaccines and uses thereof |
| 03/02/1999 | US5876724 Induction of neutralizing antibody against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein |
| 03/02/1999 | US5876723 Purified human papillomavirus type 33 (HPV-33) peptides as an immunogenic composition |
| 03/02/1999 | US5876716 Aids therapy |
| 03/02/1999 | US5876693 Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals |
| 03/02/1999 | CA2242315A1 Mecb |
| 03/02/1999 | CA2242252A1 Dexb |
| 03/02/1999 | CA2241417A1 Novel ffh |
| 03/02/1999 | CA2165419C Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 03/02/1999 | CA2062001C Stabilized pvp-i solutions |
| 03/02/1999 | CA1340414C Inactivation of human immunodeficiency virus (hiv) in protein-containing solutions by phenols |
| 02/28/1999 | CA2246118A1 Substituted quinolone derivatives and pharmaceuticals containing the same |
| 02/28/1999 | CA2241427A1 Novel pyrr homolog |
| 02/28/1999 | CA2241424A1 Novel ftsy |
| 02/28/1999 | CA2241420A1 Novel folc |
| 02/28/1999 | CA2241400A1 Ftsy |
| 02/27/1999 | CA2233681A1 Novel div1b |
| 02/26/1999 | CA2241431A1 Novel spoiiie |
| 02/26/1999 | CA2241410A1 Pth |
| 02/25/1999 | WO1999009186A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 02/25/1999 | WO1999009176A1 Neisseria lactoferrin binding protein |
| 02/25/1999 | WO1999009162A2 Delayed progression to aids by a missense allele of the ccr2 gene |
| 02/25/1999 | WO1999009154A2 Novel hiv-specific synthetic oligonucleotides and methods of their use |
| 02/25/1999 | WO1999009032A1 Carbapenems with naphthosultam derivative linked via methylene |
| 02/25/1999 | WO1999009031A1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
| 02/25/1999 | WO1999009017A1 Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use |
| 02/25/1999 | WO1999009014A1 Hiv nuclear localization inhibitors |
| 02/25/1999 | WO1999009005A1 Hiv matrix protein tyrosine position 29 pocket binders |
| 02/25/1999 | WO1999008706A1 Recombinant porcine adenovirus vector |
| 02/25/1999 | WO1999008705A1 Capsular polysaccharides from enterococci |
| 02/25/1999 | WO1999008704A1 Method of protecting against chronic infections |
| 02/25/1999 | WO1999008703A1 Anti-viral treatment with pertussis toxin b oligomer |
| 02/25/1999 | WO1999008691A2 Use of locally delivered metal ions for treatment of periodontal disease |
| 02/25/1999 | WO1999008663A1 Parenteral pimaricin as treatment of systemic infections |
| 02/25/1999 | WO1998053101A3 Methods and composition to identify swine genetically resistant to f18 e. coli associated diseases |
| 02/25/1999 | WO1998045259A3 Polyaromatic antiviral compositions |
| 02/25/1999 | DE19833750A1 New thiazolyl-alkadienol and -epoxide derivatives |
| 02/25/1999 | DE19736772A1 New guanidino-substituted bi:cyclic peptide compounds |
| 02/25/1999 | CA2301374A1 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 02/25/1999 | CA2301332A1 Neisseria lactoferrin binding protein |
| 02/25/1999 | CA2301227A1 Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use |
| 02/25/1999 | CA2301065A1 Use of locally delivered metal ions for treatment of periodontal disease |
| 02/25/1999 | CA2300431A1 Anti-viral treatment with pertussis toxin b oligomer |
| 02/25/1999 | CA2300352A1 Novel hiv-specific synthetic oligonucleotides and methods of their use |
| 02/25/1999 | CA2300093A1 Delayed progression to aids by a missense allele of the ccr2 gene |
| 02/25/1999 | CA2298997A1 Carbapenems with naphthosultam derivative linked via methylene |
| 02/25/1999 | CA2295478A1 Parenteral pimaricin as treatment of systemic infections |
| 02/25/1999 | CA2241430A1 Novel murb |
| 02/25/1999 | CA2241403A1 Murb |
| 02/24/1999 | EP0897980A2 CXCR4B: A human splice variant of CXCR4 chemokine receptor |
| 02/24/1999 | EP0897979A2 Human sdr2 cdna clone |